Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)

Clinical trial NCT02765165 · TERMINATED

Trial details

NCT number: NCT02765165
Sponsor: Proximagen, LLC
Status: TERMINATED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumors (Phase 1)Relapsed/Recurrent GBM (Phase 2)

Start date: 2016-04-01
Primary completion: 2020-07-01
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.